Since the first generation of a negative-sense RNA virus entirely from cloned cDNA in 1994, similar reverse genetics systems have been established for members of most genera of the Rhabdo- and Paramyxoviridae families, as well as for Ebola virus (Filoviridae). The generation of segmented negative-sense RNA viruses was technically more challenging and has lagged behind the recovery of nonsegmented viruses, primarily because of the difficulty of providing more than one genomic RNA segment. A member of the Bunyaviridae family (whose genome is composed of three RNA segments) was first generated from cloned cDNA in 1996, followed in 1999 by the production of influenza virus, which contains eight RNA segments. Thus, reverse genetics, or the de novo synthesis of negative-sense RNA viruses from cloned cDNA, has become a reliable laboratory method that can be used to study this large group of medically and economically important viruses. It provides a powerful tool for dissecting the virus life cycle, virus assembly, the role of viral proteins in pathogenicity and the interplay of viral proteins with components of the host cell immune response. Finally, reverse genetics has opened the way to develop live attenuated virus vaccines and vaccine vectors.
AtreyaP. L.,
KulkarniS.1999; Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology 261:227–241
AtreyaP. L.,
PeeplesM. E.,
CollinsP. L.1998; The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. Journal of Virology 72:1452–1461
BaillyJ. E.,
McAuliffeJ. M.,
DurbinA. P.,
ElkinsW. R.,
CollinsP. L.,
MurphyB. R.2000; A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates. Journal of Virology 74:3188–3195
BallL. A.,
PringleC. R.,
FlanaganB.,
PerepelitsaV. P.,
WertzG. W.1999; Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus. Journal of Virology 73:4705–4712
BaronM. D.,
BarrettT.2000; Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. Journal of Virology 74:2603–2611
BarrJ. N.,
WertzG. W.2001; Polymerase slippage at vesicular stomatitis virus gene junctions to generate poly(A) is regulated by the upstream 3′-AUAC-5′ tetranucleotide: implications for the mechanism of transcription termination. Journal of Virology 75:6901–6913
BarrJ. N.,
WhelanS. P.,
WertzG. W.1997a; Cis -acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation. Journal of Virology 71:8718–8725
BarrJ. N.,
WhelanS. P.,
WertzG. W.1997b; Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. Journal of Virology 71:1794–1801
BaslerC. F.,
ReidA. H.,
DybingJ. K.,
JanczewskiT. A.,
FanningT. G.,
ZhengH.,
SalvatoreM.,
PerdueM. L.,
SwayneD. E.,
Garcia-SastreA.,
PaleseP.,
TaubenbergerJ. K.2001; From the cover: sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proceedings of the National Academy of Sciences, USA 98:2746–2751
BelsheR. B.,
MendelmanP. M.,
TreanorJ.,
KingJ.,
GruberW. C.,
PiedraP.,
BernsteinD. I.,
HaydenF. G.,
KotloffK.,
ZangwillK.,
IacuzioD.,
WolffM.1998; The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine 338:1405–1412
BergmannM.,
MusterT.1996; Mutations in the nonconserved noncoding sequences of the influenza A virus segments affect viral vRNA formation. Virus Research 44:23–31
BerminghamA.,
CollinsP. L.1999; The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proceedings of the National Academy of Sciences, USA 96:11259–11264
BilselP.,
CastrucciM. R.,
KawaokaY.1993; Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions. Journal of Virology 67:6762–6767
BoritzE.,
GerlachJ.,
JohnsonJ. E.,
RoseJ. K.1999; Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. Journal of Virology 73:6937–6945
BoyceT. G.,
PolandG. A.2000; Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review. Biomedicine & Pharmacotherapy 54:210–218
BridgenA.,
ElliottR. M.1996; Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proceedings of the National Academy of Sciences, USA 93:15400–15404
BuchholzU. J.,
FinkeS.,
ConzelmannK. K.1999; Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. Journal of Virology 73:251–259
BuchholzU. J.,
GranzowH.,
SchuldtK.,
WhiteheadS. S.,
MurphyB. R.,
CollinsP. L.2000; Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine. Journal of Virology 74:1187–1199
BuchmeierM. J.,
BowenM. D.,
PetersC. J.2001; Arenaviridae : The viruses and their replication. InFields Virology pp 1635–1668 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
BukreyevA.,
WhiteheadS. S.,
MurphyB. R.,
CollinsP. L.1997; Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. Journal of Virology 71:8973–8982
BukreyevA.,
WhiteheadS. S.,
BukreyevaN.,
MurphyB. R.,
CollinsP. L.1999; Interferon-γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proceedings of the National Academy of Sciences, USA 96:2367–2372
BukreyevA.,
MurphyB. R.,
CollinsP. L.2000a; Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo . Journal of Virology 74:11017–11026
BukreyevA.,
WhiteheadS. S.,
PrussinC.,
MurphyB. R.,
CollinsP. L.2000b; Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines. Journal of Virology 74:7151–7157
CalainP.,
RouxL.1993; The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. Journal of Virology 67:4822–4830
CalainP.,
CurranJ.,
KolakofskyD.,
RouxL.1992; Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 191:62–71
CastrucciM. R.,
KawaokaY.1995; Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. Journal of Virology 69:2725–2728
CastrucciM. R.,
BilselP.,
KawaokaY.1992; Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. Journal of Virology 66:4647–4653
CastrucciM. R.,
HouS.,
DohertyP. C.,
KawaokaY.1994; Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes. Journal of Virology 68:3486–3490
CastrucciM. R.,
HughesM.,
CalzolettiL.,
DonatelliI.,
WellsK.,
TakadaA.,
KawaokaY.1997; The cysteine residues of the M2 protein are not required for influenza A virus replication. Virology 238:128–134
CathomenT.,
MrkicB.,
SpehnerD.,
DrillienR.,
NaefR.,
PavlovicJ.,
AguzziA.,
BilleterM. A.,
CattaneoR.1998a; A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO Journal 17:3899–3908
CathomenT.,
NaimH. Y.,
CattaneoR.1998b; Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. Journal of Virology 72:1224–1234
ChengX.,
ZhouH.,
TangR. S.,
MunozM. G.,
JinH.2001; Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys. Virology 283:59–68
CollinsP. L.,
MinkM. A.,
StecD. S.1991; Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proceedings of the National Academy of Sciences, USA 88:9663–9667
CollinsP. L.,
HillM. G.,
CamargoE.,
GrosfeldH.,
ChanockR. M.,
MurphyB. R.1995; Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proceedings of the National Academy of Sciences, USA 92:11563–11567
CollinsP. L.,
HillM. G.,
CristinaJ.,
GrosfeldH.1996; Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proceedings of the National Academy of Sciences, USA 93:81–85
CollinsP. L.,
WhiteheadS. S.,
BukreyevA.,
FearnsR.,
TengM. N.,
JuhaszK.,
ChanockR. M.,
MurphyB. R.1999; Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Advances in Virus Research 54:423–451
ConzelmannK. K.,
CoxJ. H.,
ThielH. J.1991; An L (polymerase)-deficient rabies virus defective interfering particle RNA is replicated and transcribed by heterologous helper virus L proteins. Virology 184:655–663
CoxN. J.,
KitameF.,
KlimovA.,
KoenneckeI.,
KendalA. P.1986; Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain. Microbial Pathogenesis 1:387–397
DasT.,
PattnaikA. K.,
TakacsA. M.,
LiT.,
HwangL. N.,
BanerjeeA. K.1997; Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA. Virology 238:103–114
DasT.,
ChakrabartiB. K.,
ChattopadhyayD.,
BanerjeeA. K.1999; Carboxy-terminal five amino acids of the nucleocapsid protein of vesicular stomatitis virus are required for encapsidation and replication of genome RNA. Virology 259:219–227
DasS. C.,
BaronM. D.,
BarrettT.2000; Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste-des-petits-ruminants virus: homologous F and H proteins are required for virus viability. Journal of Virology 74:9039–9047
DeB. P.,
GuptaS.,
BanerjeeA. K.1995; Cellular protein kinase C isoform ζ regulates human parainfluenza virus type 3 replication. Proceedings of the National Academy of Sciences, USA 92:5204–5208
DeB. P.,
HoffmanM. A.,
ChoudharyS.,
HuntleyC. C.,
BanerjeeA. K.2000; Role of NH2- and COOH-terminal domains of the P protein of human parainfluenza virus type 3 in transcription and replication. Journal of Virology 74:5886–5895
DelendaC.,
HausmannS.,
GarcinD.,
KolakofskyD.1997; Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228:55–62
DidcockL.,
YoungD. F.,
GoodbournS.,
RandallR. E.1999b; The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. Journal of Virology 73:9928–9933
DimockK.,
CollinsP. L.1993; Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3. Journal of Virology 67:2772–2778
DonnellyM. L.,
HughesL. E.,
LukeG.,
MendozaH.,
ten DamE.,
GaniD.,
RyanM. D.2001; The ‘cleavage’ activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring ‘2A-like’ sequences. Journal of General Virology 82:1027–1041
DuprexW. P.,
DuffyI.,
McQuaidS.,
HamillL.,
CosbyS. L.,
BilleterM. A.,
Schneider-SchauliesJ.,
ter MeulenV.,
RimaB. K.1999; The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. Journal of Virology 73:6916–6922
DurbinA. P.,
HallS. L.,
SiewJ. W.,
WhiteheadS. S.,
CollinsP. L.,
MurphyB. R.1997a; Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 235:323–332
DurbinA. P.,
SiewJ. W.,
MurphyB. R.,
CollinsP. L.1997b; Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology 234:74–83
DurbinA. P.,
McAuliffeJ. M.,
CollinsP. L.,
MurphyB. R.1999; Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 261:319–330
DurbinA. P.,
SkiadopoulosM. H.,
McAuliffeJ. M.,
RiggsJ. M.,
SurmanS. R.,
CollinsP. L.,
MurphyB. R.2000; Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy. Journal of Virology 74:6821–6831
EnamiM.,
LuytjesW.,
KrystalM.,
PaleseP.1990; Introduction of site-specific mutations into the genome of influenza virus. Proceedings of the National Academy of Sciences, USA 87:3802–3805
EscoffierC.,
ManieS.,
VincentS.,
MullerC. P.,
BilleterM.,
GerlierD.1999; Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. Journal of Virology 73:1695–1698
FearnsR.,
CollinsP. L.1999; Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. Journal of Virology 73:5852–5864
FearnsR.,
PeeplesM. E.,
CollinsP. L.1997; Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236:188–201
FearnsR.,
CollinsP. L.,
PeeplesM. E.2000; Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus. Journal of Virology 74:6006–6014
FinkeS.,
ConzelmannK. K.1999; Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3′ copy-back ambisense rabies virus. Journal of Virology 73:3818–3825
FlanaganE. B.,
BallL. A.,
WertzG. W.2000; Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response. Journal of Virology 74:7895–7902
FlanaganE. B.,
ZamparoJ. M.,
BallL. A.,
RodriguezL. L.,
WertzG. W.2001; Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. Journal of Virology 75:6107–6114
FlickR.,
HobomG.1999; Interaction of influenza virus polymerase with viral RNA in the ‘corkscrew’ conformation. Journal of General Virology 80:2565–2572
FodorE.,
SeongB. L.,
BrownleeG. G.1993; Photochemical cross-linking of influenza A polymerase to its virion RNA promoter defines a polymerase binding site at residues 9 to 12 of the promoter. Journal of General Virology 74:1327–1333
FodorE.,
PritloveD. C.,
BrownleeG. G.1994; The influenza virus panhandle is involved in the initiation of transcription. Journal of Virology 68:4092–4096
FodorE.,
PritloveD. C.,
BrownleeG. G.1995; Characterization of the RNA-fork model of virion RNA in the initiation of transcription in influenza A virus. Journal of Virology 69:4012–4019
FodorE.,
DevenishL.,
EngelhardtO. G.,
PaleseP.,
BrownleeG. G.,
Garcia-SastreA.1999; Rescue of influenza A virus from recombinant DNA. Journal of Virology 73:9679–9682
Fouillot-CoriouN.,
RouxL.2000; Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: different role for the two proteins in the production of virus particle. Virology 270:464–475
Garcia-SastreA.2001; Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375–384
Garcia-SastreA.,
PaleseP.1995; The cytoplasmic tail of the neuraminidase protein on influenza A virus does not play an important role in the packaging of this protein into viral envelopes. Virus Research 37:37–47
Garcia-SastreA.,
MusterT.,
BarclayW. S.,
PercyN.,
PaleseP.1994a; Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. Journal of Virology 68:6254–6261
Garcia-SastreA.,
PercyN.,
BarclayW.,
PaleseP.1994b; Introduction of foreign sequences into the genome of influenza A virus. Developments in Biological Standardization 82:237–246
Garcia-SastreA.,
EgorovA.,
MatassovD.,
BrandtS.,
LevyD. E.,
DurbinJ. E.,
PaleseP.,
MusterT.1998; Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330
GarcinD.,
PeletT.,
CalainP.,
RouxL.,
CurranJ.,
KolakofskyD.1995; A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO Journal 14:6087–6094
GarcinD.,
ItohM.,
KolakofskyD.1997; A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology 238:424–431
GarcinD.,
LatorreP.,
KolakofskyD.1999; Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. Journal of Virology 73:6559–6565
GarcinD.,
CurranJ.,
KolakofskyD.2000; Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. Journal of Virology 74:8823–8830
GarcinD.,
CurranJ.,
ItohM.,
KolakofskyD.2001; Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. Journal of Virology 75:6800–6807
GillelandH. E.Jr,
GillelandL. B.,
StaczekJ.,
HartyR. N.,
Garcia-SastreA.,
EngelhardtO. G.,
PaleseP.1997; Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa . Behring Institute Mitteilungen 98:291–301
Gomez-PuertasP.,
MenaI.,
CastilloM.,
VivoA.,
Perez-PastranaE.,
PortelaA.1999; Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins. Journal of General Virology 80:1635–1645
Gomez-PuertasP.,
AlboC.,
Perez-PastranaE.,
VivoA.,
PortelaA.2000; Influenza virus matrix protein is the major driving force in virus budding. Journal of Virology 74:11538–11547
GotoH.,
KawaokaY.1998; A novel mechanism for the acquisition of virulence by a human influenza A virus. Proceedings of the National Academy of Sciences, USA 95:10224–10228
GotoH.,
WellsK.,
TakadaA.,
KawaokaY.2001; Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. Journal of Virology 75:9297–9301
GotohB.,
TakeuchiK.,
KomatsuT.,
YokooJ.,
KimuraY.,
KurotaniA.,
KatoA.,
NagaiY.1999; Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/ β-mediated responses. FEBS Letters 459:205–210
HaglundK.,
FormanJ.,
KrausslichH. G.,
RoseJ. K.2000; Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 268:112–121
HallerA. A.,
MillerT.,
MitikuM.,
CoelinghK.2000; Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. Journal of Virology 74:11626–11635
HardyR. W.,
WertzG. W.1998; The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. Journal of Virology 72:520–526
HardyR. W.,
HarmonS. B.,
WertzG. W.1999; Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination. Journal of Virology 73:170–176
HartyR. N.,
PaleseP.1995; Mutations within noncoding terminal sequences of model RNAs of Sendai virus: influence on reporter gene expression. Journal of Virology 69:5128–5131
HasanM. K.,
KatoA.,
ShiodaT.,
SakaiY.,
YuD.,
NagaiY.1997; Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. Journal of General Virology 78:2813–2820
HasanM. K.,
KatoA.,
MuranakaM.,
YamaguchiR.,
SakaiY.,
HatanoI.,
TashiroM.,
NagaiY.2000; Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. Journal of Virology 74:5619–5628
HatadaE.,
SaitoS.,
FukudaR.1999; Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. Journal of Virology 73:2425–2433
HeB.,
LambR. A.1999; Effect of inserting paramyxovirus simian virus 5 gene junctions at the HN/L gene junction: analysis of accumulation of mRNAs transcribed from rescued viable viruses. Journal of Virology 73:6228–6234
HeB.,
LeserG. P.,
PatersonR. G.,
LambR. A.1998; The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 250:30–40
HeB.,
LinG. Y.,
DurbinJ. E.,
DurbinR. K.,
LambR. A.2001; The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. Journal of Virology 75:4068–4079
HerlocherM. L.,
ClavoA. C.,
MaassabH. F.1996; Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation. Virus Research 42:11–25
HoffmanM. A.,
BanerjeeA. K.2000b; Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology 269:201–211
HoffmannE.,
WebsterR. G.2000; Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. Journal of General Virology 81:2843–2847
HoffmannE.,
NeumannG.,
HobomG.,
WebsterR. G.,
KawaokaY.2000a; ‘Ambisense’ approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267:310–317
HoffmannE.,
NeumannG.,
KawaokaY.,
HobomG.,
WebsterR. G.2000b; A DNA transfection system for generation of influenza A virus from eight plasmids. Proceedings of the National Academy of Sciences, USA 97:6108–6113
HondaA.,
UedaK.,
NagataK.,
IshihamaA.1987; Identification of the RNA polymerase-binding site on genome RNA of influenza virus. Journal of Biochemistry 102:1241–1249
HondaA.,
UedaK.,
NagataK.,
IshihamaA.1988; RNA polymerase of influenza virus: role of NP in RNA chain elongation. Journal of Biochemistry 104:1021–1026
HorikamiS. M.,
CurranJ.,
KolakofskyD.,
MoyerS. A.1992; Complexes of Sendai virus NP–P and P–L proteins are required for defective interfering particle genome replication in vitro . Journal of Virology 66:4901–4908
HorimotoT.,
KawaokaY.1994; Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. Journal of Virology 68:3120–3128
HsuM. T.,
ParvinJ. D.,
GuptaS.,
KrystalM.,
PaleseP.1987; Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proceedings of the National Academy of Sciences, USA 84:8140–8144
HuC. J.,
KatoA.,
BowmanM. C.,
KiyotaniK.,
YoshidaT.,
MoyerS. A.,
NagaiY.,
GuptaK. C.1999; Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis. Virology 263:195–208
HuangC.,
KiyotaniK.,
FujiiY.,
FukuharaN.,
KatoA.,
NagaiY.,
YoshidaT.,
SakaguchiT.2000; Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. Journal of Virology 74:7834–7841
HwangL. N.,
EnglundN.,
DasT.,
BanerjeeA. K.,
PattnaikA. K.1999; Optimal replication activity of vesicular stomatitis virus RNA polymerase requires phosphorylation of a residue(s) at carboxy-terminal domain II of its accessory subunit, phosphoprotein P. Journal of Virology 73:5613–5620
IsobeH.,
MoranT.,
LiS.,
YoungA.,
NathensonS.,
PaleseP.,
BonaC.1995; Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant. Journal of Experimental Medicine 181:203–213
ItoN.,
TakayamaM.,
YamadaK.,
SugiyamaM.,
MinamotoN.2001; Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice. Journal of Virology 75:9121–9128
JayakarH. R.,
MurtiK. G.,
WhittM. A.2000; Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. Journal of Virology 74:9818–9827
JinH.,
LeserG. P.,
LambR. A.1994; The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO Journal 13:5504–5515
JinH.,
SubbaraoK.,
BagaiS.,
LeserG. P.,
MurphyB. R.,
LambR. A.1996; Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. Journal of Virology 70:1406–1414
JinH.,
ChengX.,
ZhouH. Z.,
LiS.,
SeddiquiA.2000a; Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents. Journal of Virology 74:74–82
JinH.,
ZhouH.,
ChengX.,
TangR.,
MunozM.,
NguyenN.2000b; Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo . Virology 273:210–218
JohnsonJ. E.,
SchnellM. J.,
BuonocoreL.,
RoseJ. K.1997; Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. Journal of Virology 71:5060–5068
JohnstonI. C.,
ter MeulenV.,
Schneider-SchauliesJ.,
Schneider-SchauliesS.1999; A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. Journal of Virology 73:6903–6915
JuhaszK.,
WhiteheadS. S.,
BuiP. T.,
BiggsJ. M.,
CroweJ. E.,
BoulangerC. A.,
CollinsP. L.,
MurphyB. R.1997; The temperature-sensitive ( ts ) phenotype of a cold-passaged ( cp ) live attenuated respiratory syncytial virus vaccine candidate, designated cpts 530, results from a single amino acid substitution in the L protein. Journal of Virology 71:5814–5819
JuhaszK.,
MurphyB. R.,
CollinsP. L.1999a; The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts 530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination. Journal of Virology 73:5176–5180
JuhaszK.,
WhiteheadS. S.,
BoulangerC. A.,
FirestoneC. Y.,
CollinsP. L.,
MurphyB. R.1999b; The two amino acid substitutions in the L protein of cpts 530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations. Vaccine 17:1416–1424
KargerA.,
SchmidtU.,
BuchholzU. J.2001; Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. Journal of General Virology 82:631–640
KarronR. A.,
BuonagurioD. A.,
GeorgiuA. F.,
WhiteheadS. S.,
AdamusJ. E.,
Clements-MannM. L.,
HarrisD. O.,
RandolphV. B.,
UdemS. A.,
MurphyB. R.,
SidhuM. S.1997a; Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro : clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proceedings of the National Academy of Sciences, USA 94:13961–13966
KarronR. A.,
WrightP. F.,
CroweJ. E.Jr,
Clements-MannM. L.,
ThompsonJ.,
MakheneM.,
CaseyR.,
MurphyB. R.1997b; Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. Journal of Infectious Diseases 176:1428–1436
KatoA.,
SakaiY.,
ShiodaT.,
KondoT.,
NakanishiM.,
NagaiY.1996; Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes to Cells 1:569–579
KatoA.,
KiyotaniK.,
SakaiY.,
YoshidaT.,
NagaiY.1997a; The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO Journal 16:578–587
KatoA.,
KiyotaniK.,
SakaiY.,
YoshidaT.,
ShiodaT.,
NagaiY.1997b; Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. Journal of Virology 71:7266–7272
KatoA.,
KiyotaniK.,
HasanM. K.,
ShiodaT.,
SakaiY.,
YoshidaT.,
NagaiY.1999; Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene. Journal of Virology 73:9237–9246
KatoA.,
OhnishiY.,
KohaseM.,
SaitoS.,
TashiroM.,
NagaiY.2001; Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. Journal of Virology 75:3802–3810
KawanoM.,
KaitoM.,
KozukaY.,
KomadaH.,
NodaN.,
NanbaK.,
TsurudomeM.,
ItoM.,
NishioM.,
ItoY.2001; Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology 284:99–112
KawaokaY.,
WebsterR. G.1988; Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proceedings of the National Academy of Sciences, USA 85:324–328
KawaokaY.,
WebsterR. G.1989; Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. Journal of Virology 63:3296–3300
KellerM. A.,
MurphyS. K.,
ParksG. D.2001; RNA replication from the simian virus 5 antigenomic promoter requires three sequence-dependent elements separated by sequence-independent spacer regions. Journal of Virology 75:3993–3998
KimH. J.,
FodorE.,
BrownleeG. G.,
SeongB. L.1997; Mutational analysis of the RNA-fork model of the influenza A virus vRNA promoter in vivo . Journal of General Virology 78:353–357
KolakofskyD.,
PeletT.,
GarcinD.,
HausmannS.,
CurranJ.,
RouxL.1998; Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. Journal of Virology 72:891–899
KretzschmarE.,
PelusoR.,
SchnellM. J.,
WhittM. A.,
RoseJ. K.1996; Normal replication of vesicular stomatitis virus without C proteins. Virology 216:309–316
KrishnamurthyS.,
HuangZ.,
SamalS. K.2000; Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278:168–182
KuoL.,
FearnsR.,
CollinsP. L.1996a; The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. Journal of Virology 70:6143–6150
KuoL.,
GrosfeldH.,
CristinaJ.,
HillM. G.,
CollinsP. L.1996b; Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus. Journal of Virology 70:6892–6901
KuoL.,
FearnsR.,
CollinsP. L.1997; Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA. Journal of Virology 71:4944–4953
LambR. A.,
KolakofskyD.2001; Paramyxoviridae : The viruses and their replication. InFields Virology pp 1305–1340 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
LambR. A.,
KrugR. M.2001; Orthomyxoviridae : The viruses and their replication. InFields Virology pp 1487–1532 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
LathamT.,
GalarzaJ. M.2001; Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of Virology 75:6154–6165
LatorreP.,
CaddT.,
ItohM.,
CurranJ.,
KolakofskyD.1998a; The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. Journal of Virology 72:5984–5993
LawsonN. D.,
StillmanE. A.,
WhittM. A.,
RoseJ. K.1995; Recombinant vesicular stomatitis viruses from DNA. Proceedings of the National Academy of Sciences, USA 92:4477–4481
LeahyM. B.,
DobbynH. C.,
BrownleeG. G.2001a; Hairpin loop structure in the 3′ arm of the influenza a virus virion RNA promoter is required for endonuclease activity. Journal of Virology 75:7042–7049
LeahyM. B.,
PritloveD. C.,
PoonL. L.,
BrownleeG. G.2001b; Mutagenic analysis of the 5′ arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity. Journal of Virology 75:134–142
LeeK. J.,
NovellaI. S.,
TengM. N.,
OldstoneM. B.,
de la TorreJ. C.2000; NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. Journal of Virology 74:3470–3477
LiT.,
PattnaikA. K.1997; Replication signals in the genome of vesicular stomatitis virus and its defective interfering particles: identification of a sequence element that enhances DI RNA replication. Virology 232:248–259
LiT.,
PattnaikA. K.1999; Overlapping signals for transcription and replication at the 3′ terminus of the vesicular stomatitis virus genome. Journal of Virology 73:444–452
LiS. Q.,
SchulmanJ. L.,
MoranT.,
BonaC.,
PaleseP.1992; Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. Journal of Virology 66:399–404
LiS.,
PolonisV.,
IsobeH.,
ZaghouaniH.,
GuineaR.,
MoranT.,
BonaC.,
PaleseP.1993a; Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. Journal of Virology 67:6659–6666
LiS.,
RodriguesM.,
RodriguezD.,
RodriguezJ. R.,
EstebanM.,
PaleseP.,
NussenzweigR. S.,
ZavalaF.1993b; Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proceedings of the National Academy of Sciences, USA 90:5214–5218
LiS.,
SchulmanJ.,
ItamuraS.,
PaleseP.1993c; Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. Journal of Virology 67:6667–6673
LinY. P.,
WhartonS. A.,
MartinJ.,
SkehelJ. J.,
WileyD. C.,
SteinhauerD. A.1997; Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology 233:402–410
LinG. Y.,
PatersonR. G.,
RichardsonC. D.,
LambR. A.1998; The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 249:189–200
LopezN.,
MullerR.,
PrehaudC.,
BouloyM.1995; The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. Journal of Virology 69:3972–3979
LuoG. X.,
LuytjesW.,
EnamiM.,
PaleseP.1991; The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. Journal of Virology 65:2861–2867
LuytjesW.,
KrystalM.,
EnamiM.,
PavinJ. D.,
PaleseP.1989; Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107–1113
MaassabH. F.,
BryantM. L.1999; The development of live attenuated cold-adapted influenza virus vaccine for humans. Reviews in Medical Virology 9:237–244
MaisnerA.,
MrkicB.,
HerrlerG.,
MollM.,
BilleterM. A.,
CattaneoR.,
KlenkH. D.2000; Recombinant measles virus requiring an exogenous protease for activation of infectivity. Journal of General Virology 2:441–449
MebatsionT.,
ConzelmannK. K.1996; Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein. Proceedings of the National Academy of Sciences, USA 93:11366–11370
MebatsionT.,
SchnellM. J.,
CoxJ. H.,
FinkeS.,
ConzelmannK. K.1996; Highly stable expression of a foreign gene from rabies virus vectors. Proceedings of the National Academy of Sciences, USA 93:7310–7314
MebatsionT.,
WeilandF.,
ConzelmannK. K.1999; Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. Journal of Virology 73:242–250
MebatsionT.,
VerstegenS.,
De VaanL. T.,
Romer-OberdorferA.,
SchrierC. C.2001; A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. Journal of Virology 75:420–428
MenaI.,
VivoA.,
PerezE.,
PortelaA.1996; Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. Journal of Virology 70:5016–5024
MitnaulL. J.,
CastrucciM. R.,
MurtiK. G.,
KawaokaY.1996; The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. Journal of Virology 70:873–879
MollM.,
KlenkH. D.,
HerrlerG.,
MaisnerA.2001; A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin–Darby canine kidney cells. Journal of Biological Chemistry 276:17887–17894
MorimotoK.,
FoleyH. D.,
McGettiganJ. P.,
SchnellM. J.,
DietzscholdB.2000; Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. Journal of Neurovirology 6:373–381
MuhlbergerE.,
LotferingB.,
KlenkH. D.,
BeckerS.1998; Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. Journal of Virology 72:8756–8764
MuhlbergerE.,
WeikM.,
VolchkovV. E.,
KlenkH. D.,
BeckerS.1999; Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. Journal of Virology 73:2333–2342
MunozF. M.,
GalassoG. J.,
GwaltneyJ. M.Jr,
HaydenF. G.,
MurphyB.,
WebsterR.,
WrightP.,
CouchR. B.2000; Current research on influenza and other respiratory viruses. II. International Symposium. Antiviral Research 46:91–124
MurataK.,
Garcia-SastreA.,
TsujiM.,
RodriguesM.,
RodriguezD.,
RodriguezJ. R.,
NussenzweigR. S.,
PaleseP.,
EstebanM.,
ZavalaF.1996; Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cellular Immunology 173:96–107
MurphyS. K.,
ParksG. D.1997; Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology 232:145–157
MurphyS. K.,
ParksG. D.1999; RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif. Journal of Virology 73:805–809
MurphyS. K.,
ItoY.,
ParksG. D.1998; A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3′ terminus. Journal of Virology 72:10–19
MusterT.,
GuineaR.,
TrkolaA.,
PurtscherM.,
KlimaA.,
SteindlF.,
PaleseP.,
KatingerH.1994; Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. Journal of Virology 68:4031–4034
MusterT.,
FerkoB.,
KlimaA.,
PurtscherM.,
TrkolaA.,
SchulzP.,
GrassauerA.,
EngelhardtO. G.,
Garcia-SastreA.,
PaleseP.and others1995; Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. Journal of Virology 69:6678–6686
NeumannG.,
KawaokaY.1999; Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes. Advances in Virus Research 53:265–300
NeumannG.,
WatanabeT.,
ItoH.,
WatanabeS.,
GotoH.,
GaoP.,
HughesM.,
PerezD. R.,
DonisR.,
HoffmannE.,
HobomG.,
KawaokaY.1999; Generation of influenza A viruses entirely from cloned cDNAs. Proceedings of the National Academy of Sciences, USA 96:9345–9350
NeumannG.,
FeldmannH.,
WatanabeS.,
LukashevichI.,
KawaokaY.2002; Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. Journal of Virology 76:406–410
OhgimotoS.,
OhgimotoK.,
NiewieskS.,
KlaggeI. M.,
PfeufferJ.,
JohnstonI. C.,
Schneider-SchauliesJ.,
WeidmannA.,
ter MeulenV.,
Schneider-SchauliesS.2001; The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro . Journal of General Virology 82:1835–1844
O’NeillR. E.,
TalonJ.,
PaleseP.1998; The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO Journal 17:288–296
PaleseP.,
ZhengH.,
EngelhardtO. G.,
PleschkaS.,
Garcia-SastreA.1996; Negative-strand RNA viruses: genetic engineering and application. Proceedings of the National Academy of Sciences, USA 93:11354–11358
ParisienJ. P.,
LauJ. F.,
RodriguezJ. J.,
SullivanB. M.,
MosconaA.,
ParksG. D.,
LambR. A.,
HorvathC. M.2001; The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283:230–239
ParkK. H.,
HuangT.,
CorreiaF. F.,
KrystalM.1991; Rescue of a foreign gene by Sendai virus. Proceedings of the National Academy of Sciences, USA 88:5537–5541
ParkinN. T.,
ChiuP.,
CoelinghK. L.1996; Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis. Virus Research 46:31–44
PattersonJ. B.,
ThomasD.,
LewickiH.,
BilleterM. A.,
OldstoneM. B.2000; V and C proteins of measles virus function as virulence factors in vivo . Virology 267:80–89
PattnaikA. K.,
WertzG. W.1990; Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. Journal of Virology 64:2948–2957
PattnaikA. K.,
WertzG. W.1991; Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles. Proceedings of the National Academy of Sciences, USA 88:1379–1383
PattnaikA. K.,
BallL. A.,
LeGroneA.,
WertzG. W.1995; The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles. Virology 206:760–764
PattnaikA. K.,
HwangL.,
LiT.,
EnglundN.,
MathurM.,
DasT.,
BanerjeeA. K.1997; Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. Journal of Virology 71:8167–8175
PeeplesM. E.,
CollinsP. L.2000; Mutations in the 5′ trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step. Journal of Virology 74:146–155
PeetersB. P.,
de LeeuwO. S.,
KochG.,
GielkensA. L.1999; Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. Journal of Virology 73:5001–5009
PeetersB. P.,
GruijthuijsenY. K.,
de LeeuwO. S.,
GielkensA. L.2000; Genome replication of Newcastle disease virus: involvement of the rule-of-six. Archives of Virology 145:1829–1845
PeetersB. P.,
de LeeuwO. S.,
VerstegenI.,
KochG.,
GielkensA. L.2001; Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine 19:1616–1627
PekoszA.,
HeB.,
LambR. A.1999; Reverse genetics of negative-strand RNA viruses: closing the circle. Proceedings of the National Academy of Sciences, USA 96:8804–8806
PeletT.,
DelendaC.,
GubbayO.,
GarcinD.,
KolakofskyD.1996; Partial characterization of a Sendai virus replication promoter and the rule of six. Virology 224:405–414
PoonL. L.,
FodorE.,
BrownleeG. G.2000; Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export. Journal of Virology 74:418–427
PritloveD. C.,
FodorE.,
SeongB. L.,
BrownleeG. G.1995; In vitro transcription and polymerase binding studies of the termini of influenza A virus cRNA: evidence for a cRNA panhandle. Journal of General Virology 76:2205–2213
PritloveD. C.,
PoonL. L.,
DevenishL. J.,
LeahyM. B.,
BrownleeG. G.1999; A hairpin loop at the 5′ end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro . Journal of Virology 73:2109–2114
RadeckeF.,
BilleterM. A.1996; The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217:418–421
RassaJ. C.,
ParksG. D.1999; Highly diverse intergenic regions of the paramyxovirus simian virus 5 cooperate with the gene end U tract in viral transcription termination and can influence reinitiation at a downstream gene. Journal of Virology 73:3904–3912
RassaJ. C.,
WilsonG. M.,
BrewerG. A.,
ParksG. D.2000; Spacing constraints on reinitiation of paramyxovirus transcription: the gene end U tract acts as a spacer to separate gene end from gene start sites. Virology 274:438–449
ReutterG. L.,
Cortese-GroganC.,
WilsonJ.,
MoyerS. A.2001; Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology 285:100–109
RobertsA.,
RoseJ. K.1998; Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology 247:1–6
RobisonC. S.,
WhittM. A.2000; The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. Journal of Virology 74:2239–2246
RoseJ. K.1996; Positive strands to the rescue again: a segmented negative-strand RNA virus derived from cloned cDNAs. Proceedings of the National Academy of Sciences, USA 93:14998–15000
RoseJ. K.,
WhittM. A.2001; Rhabdoviridae : The viruses and their replication. InFields Virology pp 1221–1244 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
RoseN. F.,
RobertsA.,
BuonocoreL.,
RoseJ. K.2000; Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. Journal of Virology 74:10903–10910
RoseN. F.,
MarxP. A.,
LuckayA.,
NixonD. F.,
MorettoW. J.,
DonahoeS. M.,
MontefioriD.,
RobertsA.,
BuonacoreL.,
RoseJ. K.2001; An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539–549
SakaguchiT.,
KiyotaniK.,
KatoA.,
AsakawaM.,
FujiiY.,
NagaiY.,
YoshidaT.1997; Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo . Virology 235:360–366
SakaguchiT.,
UchiyamaT.,
FujiiY.,
KiyotaniK.,
KatoA.,
NagaiY.,
KawaiA.,
YoshidaT.1999; Double-layered membrane vesicles released from mammalian cells infected with Sendai virus expressing the matrix protein of vesicular stomatitis virus. Virology 263:230–243
SamalS. K.,
CollinsP. L.1996; RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. Journal of Virology 70:5075–5082
SanchezA.,
TrappierS. G.,
MahyB. W.,
PetersC. J.,
NicholS. T.1996; The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proceedings of the National Academy of Sciences, USA 93:3602–3607
SanchezA.,
KhanA. S.,
ZakiS. R.,
NabelG. J.,
KsiazekT. G.,
PetersC. J.2001; Filoviridae : Marburg and Ebola Viruses. In Fields Virology pp 1279–1304 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
SchmaljohnC. S.,
HooperJ. W.2001; Bunyaviridae : The viruses and their replication. In Fields Virology pp 1581–1602 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott Williams & Wilkins;
SchmidtA. C.,
McAuliffeJ. M.,
MurphyB. R.,
CollinsP. L.2001; Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. Journal of Virology 75:4594–4603
SchmittA. P.,
HeB.,
LambR. A.1999; Involvement of the cytoplasmic domain of the hemagglutinin–neuraminidase protein in assembly of the paramyxovirus simian virus 5. Journal of Virology 73:8703–8712
SchneiderH.,
KaelinK.,
BilleterM. A.1997a; Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227:314–322
SchnellM. J.,
BuonocoreL.,
KretzschmarE.,
JohnsonE.,
RoseJ. K.1996a; Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proceedings of the National Academy of Sciences, USA 93:11359–11365
SchnellM. J.,
BuonocoreL.,
WhittM. A.,
RoseJ. K.1996b; The minimal conserved transcription stop–start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. Journal of Virology 70:2318–2323
SchnellM. J.,
JohnsonJ. E.,
BuonocoreL.,
RoseJ. K.1997; Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90:849–857
SchnellM. J.,
FoleyH. D.,
SilerC. A.,
McGettiganJ. P.,
DietzscholdB.,
PomerantzR. J.2000; Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proceedings of the National Academy of Sciences, USA 97:3544–3549
SeongB. L.,
BrownleeG. G.1992a; A new method for reconstituting influenza polymerase and RNA in vitro : a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo . Virology 186:247–260
SeongB. L.,
BrownleeG. G.1992b; Nucleotides 9 to 11 of the influenza A virion RNA promoter are crucial for activity in vitro . Journal of General Virology 73:3115–3124
SidhuM. S.,
ChanJ.,
KaelinK.,
SpielhoferP.,
RadeckeF.,
SchneiderH.,
MasurekarM.,
DowlingP. C.,
BilleterM. A.,
UdemS. A.1995; Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene. Virology 208:800–807
SkiadopoulosM. H.,
DurbinA. P.,
TatemJ. M.,
WuS. L.,
PaschalisM.,
TaoT.,
CollinsP. L.,
MurphyB. R.1998; Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp 45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes. Journal of Virology 72:1762–1768
SkiadopoulosM. H.,
SurmanS.,
TatemJ. M.,
PaschalisM.,
WuS. L.,
UdemS. A.,
DurbinA. P.,
CollinsP. L.,
MurphyB. R.1999a; Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 ( cp 45) human parainfluenza virus 3 candidate vaccine. Journal of Virology 73:1374–1381
SkiadopoulosM. H.,
SurmanS. R.,
St ClaireM.,
ElkinsW. R.,
CollinsP. L.,
MurphyB. R.1999b; Attenuation of the recombinant human parainfluenza virus type 3 cp 45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts 530 L polymerase mutation. Virology 260:125–135
SkiadopoulosM. H.,
TaoT.,
SurmanS. R.,
CollinsP. L.,
MurphyB. R.1999c; Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp 45 vaccine virus with their PIV1 counterparts. Vaccine 18:503–510
SkiadopoulosM. H.,
SurmanS. R.,
DurbinA. P.,
CollinsP. L.,
MurphyB. R.2000; Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes. Virology 272:225–234
SkiadopoulosM. H.,
SurmanS. R.,
RiggsJ. M.,
CollinsP. L.,
MurphyB. R.2001; A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys. Journal of Virology 75:10498–10504
SpadaforaD.,
CanterD. M.,
JacksonR. L.,
PerraultJ.1996; Constitutive phosphorylation of the vesicular stomatitis virus P protein modulates polymerase complex formation but is not essential for transcription or replication. Journal of Virology 70:4538–4548
Stieneke-GroberA.,
VeyM.,
AnglikerH.,
ShawE.,
ThomasG.,
RobertsC.,
KlenkH. D.,
GartenW.1992; Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO Journal 11:2407–2414
StillmanE. A.,
WhittM. A.1997; Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. Journal of Virology 71:2127–2137
StillmanE. A.,
WhittM. A.1998; The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation. Journal of Virology 72:5565–5572
StillmanE. A.,
WhittM. A.1999; Transcript initiation and 5′-end modifications are separable events during vesicular stomatitis virus transcription. Journal of Virology 73:7199–7209
SubbaraoE. K.,
ParkE. J.,
LawsonC. M.,
ChenA. Y.,
MurphyB. R.1995; Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. Journal of Virology 69:5969–5977
SzewczykB.,
LaverW. G.,
SummersD. F.1988; Purification, thioredoxin renaturation, and reconstituted activity of the three subunits of the influenza A virus RNA polymerase. Proceedings of the National Academy of Sciences, USA 85:7907–7911
TakedaM.,
PekoszA.,
ShuckK.,
PintoL. H.,
LambR. A.2002; Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture. Journal of Virology 76:1391–1399
TakeuchiK.,
TakedaM.,
MiyajimaN.,
KobuneF.,
TanabayashiK.,
TashiroM.2002; Recombinant wild-type and Edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. Journal of Virology 76:4891–4900
TalonJ.,
HorvathC. M.,
PolleyR.,
BaslerC. F.,
MusterT.,
PaleseP.,
Garcia-SastreA.2000a; Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. Journal of Virology 74:7989–7996
TalonJ.,
SalvatoreM.,
O’NeillR. E.,
NakayaY.,
ZhengH.,
MusterT.,
Garcia-SastreA.,
PaleseP.2000b; Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proceedings of the National Academy of Sciences, USA 97:4309–4314
TaoT.,
DurbinA. P.,
WhiteheadS. S.,
DavoodiF.,
CollinsP. L.,
MurphyB. R.1998; Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin–neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1. Journal of Virology 72:2955–2961
TaoT.,
SkiadopoulosM. H.,
DurbinA. P.,
DavoodiF.,
CollinsP. L.,
MurphyB. R.1999; A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge. Vaccine 17:1100–1108
TaoT.,
DavoodiF.,
ChoC. J.,
SkiadopoulosM. H.,
DurbinA. P.,
CollinsP. L.,
MurphyB. R.2000a; A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin–neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3. Vaccine 18:1359–1366
TaoT.,
SkiadopoulosM. H.,
DavoodiF.,
RiggsJ. M.,
CollinsP. L.,
MurphyB. R.2000b; Replacement of the ectodomains of the hemagglutinin–neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates. Journal of Virology 74:6448–6458
TapparelC.,
RouxL.1996; The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity. Virology 225:163–171
TapparelC.,
HausmannS.,
PeletT.,
CurranJ.,
KolakofskyD.,
RouxL.1997; Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. Journal of Virology 71:9588–9599
TapparelC.,
MauriceD.,
RouxL.1998; The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. Journal of Virology 72:3117–3128
TengM. N.,
CollinsP. L.1999; Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. Journal of Virology 73:466–473
TengM. N.,
WhiteheadS. S.,
BerminghamA.,
St ClaireM.,
ElkinsW. R.,
MurphyB. R.,
CollinsP. L.2000; Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. Journal of Virology 74:9317–9321
TengM. N.,
WhiteheadS. S.,
CollinsP. L.2001; Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo . Virology 289:282–296
ThomasJ. M.,
StevensM. P.,
PercyN.,
BarclayW. S.1998; Phosphorylation of the M2 protein of influenza A virus is not essential for virus viability. Virology 252:54–64
TileyL. S.,
HagenM.,
MatthewsJ. T.,
KrystalM.1994; Sequence-specific binding of the influenza virus RNA polymerase to sequences located at the 5′ ends of the viral RNAs. Journal of Virology 68:5108–5116
ToberC.,
SeufertM.,
SchneiderH.,
BilleterM. A.,
JohnstonI. C.,
NiewieskS.,
ter MeulenV.,
Schneider-SchauliesS.1998; Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. Journal of Virology 72:8124–8132
ValsamakisA.,
SchneiderH.,
AuwaerterP. G.,
KaneshimaH.,
BilleterM. A.,
GriffinD. E.1998; Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo . Journal of Virology 72:7754–7761
VolchkovV. E.,
BeckerS.,
VolchkovaV. A.,
TernovojV. A.,
KotovA. N.,
NetesovS. V.,
KlenkH. D.1995; GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214:421–430
VolchkovV. E.,
VolchkovaV. A.,
MuhlbergerE.,
KolesnikovaL. V.,
WeikM.,
DolnikO.,
KlenkH. D.2001; Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291:1965–1969
von MesslingV.,
ZimmerG.,
HerrlerG.,
HaasL.,
CattaneoR.2001; The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. Journal of Virology 75:6418–6427
WalkerW. S.,
CastrucciM. R.,
SangsterM. Y.,
CarsonR. T.,
KawaokaY.1997; HEL-Flu: an influenza virus containing the hen egg lysozyme epitope recognized by CD4+ T cells from mice transgenic for an αβ TCR. Journal of Immunology 159:2563–2566
WalshE. P.,
BaronM. D.,
AndersonJ.,
BarrettT.2000a; Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. Journal of General Virology 81:709–718
WalshE. P.,
BaronM. D.,
RennieL. F.,
MonaghanP.,
AndersonJ.,
BarrettT.2000b; Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. Journal of Virology 74:10165–10175
WangX.,
LiM.,
ZhengH.,
MusterT.,
PaleseP.,
BegA. A.,
Garcia-SastreA.2000; Influenza A virus NS1 protein prevents activation of NF-κB and induction of α/β interferon. Journal of Virology 74:11566–11573
WatanabeT.,
WatanabeS.,
ItoH.,
KidaH.,
KawaokaY.2001; Influenza a virus can undergo multiple cycles of replication without M2 ion channel activity. Journal of Virology 75:5656–5662
WertzG. W.,
WhelanS.,
LeGroneA.,
BallL. A.1994; Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. Proceedings of the National Academy of Sciences, USA 91:8587–8591
WertzG. W.,
PerepelitsaV. P.,
BallL. A.1998; Gene arrangement attenuates expression and lethality of a nonsegmented strand RNA virus. Proceedings of the National Academy of Sciences, USA 95:3501–3506
WhelanS. P. J.,
WertzG. W.1999; Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: identification of distinct sequences essential for transcription but not replication. Journal of Virology 73:297–306
WhelanS. P.,
BallL. A.,
BarrJ. N.,
WertzG. T.1995; Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proceedings of the National Academy of Sciences, USA 92:8388–8392
WhelanS. P.,
BarrJ. N.,
WertzG. W.2000; Identification of a minimal size requirement for termination of vesicular stomatitis virus mRNA: implications for the mechanism of transcription. Journal of Virology 74:8268–8276
WhiteheadS. S.,
FirestoneC. Y.,
CollinsP. L.,
MurphyB. R.1998a; A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts 248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Virology 247:232–239
WhiteheadS. S.,
JuhaszK.,
FirestoneC. Y.,
CollinsP. L.,
MurphyB. R.1998b; Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees. Journal of Virology 72:4467–4471
WhiteheadS. S.,
BukreyevA.,
TengM. N.,
FirestoneC. Y.,
St ClaireM.,
ElkinsW. R.,
CollinsP. L.,
MurphyB. R.1999a; Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. Journal of Virology 73:3438–3442
WhiteheadS. S.,
FirestoneC. Y.,
KarronR. A.,
CroweJ. E.Jr,
ElkinsW. R.,
CollinsP. L.,
MurphyB. R.1999b; Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts 530/1030 to RSV vaccine candidate cpts 248/404 increases its attenuation and temperature sensitivity. Journal of Virology 73:871–877
WhiteheadS. S.,
HillM. G.,
FirestoneC. Y.,
St ClaireM.,
ElkinsW. R.,
MurphyB. R.,
CollinsP. L.1999c; Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. Journal of Virology 73:9773–9780
YamanakaK.,
OgasawaraN.,
YoshikawaH.,
IshihamaA.,
NagataK.1991; In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA. Proceedings of the National Academy of Sciences, USA 88:5369–5373
YoshidaT.,
ShawM. W.,
YoungJ. F.,
CompansR. W.1981; Characterization of the RNA associated with influenza A cytoplasmic inclusions and the interaction of NS1 protein with RNA. Virology 110:87–97
YoungD. F.,
ChatziandreouN.,
HeB.,
GoodbournS.,
LambR. A.,
RandallR. E.2001; Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. Journal of Virology 75:3363–3370
YuD.,
ShiodaT.,
KatoA.,
HasanM. K.,
SakaiY.,
NagaiY.1997; Sendai virus-based expression of HIV-1 gp120: reinforcement by the V− version. Genes to Cells 2:457–466
YunusA. S.,
CollinsP. L.,
SamalS. K.1998; Sequence analysis of a functional polymerase (L) gene of bovine respiratory syncytial virus: determination of minimal trans -acting requirements for RNA replication. Journal of General Virology 79:2231–2238
ZhangJ.,
LeserG. P.,
PekoszA.,
LambR. A.2000; The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology 269:325–334
ZhengH.,
PaleseP.,
Garcia-SastreA.1996; Nonconserved nucleotides at the 3′ and 5′ ends of an influenza A virus RNA play an important role in viral RNA replication. Virology 217:242–251
ZhengH.,
LeeH. A.,
PaleseP.,
Garcia-SastreA.1999; Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication. Journal of Virology 73:5240–5243
ZurcherT.,
LuoG.,
PaleseP.1994; Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation. Journal of Virology 68:5748–5754